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Herpes simplex virus type 1 (HSV-1) mutants were selected by passage of HSV-1(KOS) in HEp-2 cells such that binding
and penetration occurred in the presence of heparin. Analysis of selected uncloned virus pools revealed that approximately
95% of virus formed syncytia and greater than 58% were gC-negative. Plaque-purified gC-negative syncytial mutants were
more resistant than HSV-1(KOS) to heparin inhibition, as was an engineered nonsyncytial recombinant deleted for gC, DgC6.
Thus, absence of gC was sufficient to explain the enrichment for gC-negative mutants. The syncytial phenotype of most
mutants mapped to a mutation in gK. Transfer of this mutation to HSV-1(KOS) resulted in a recombinant that induced fusion
of Vero cells but not HEp-2 cells and was more sensitive to heparin inhibition of entry, revealing a previously undescribed
phenotype of mutations in gK. Engineered gC-negative virus containing the gK syncytial mutation induced fusion of both
cell lines and was as resistant to heparin inhibition as was DgC6. Because deletion of gC reduces infectivity of HSV-1 in
the absence of heparin, mutations in gC combined with the syncytial mutation could have provided a selective advantage.
Thus, absence of gC reduced heparin inhibition of binding and penetration while the combination of the gC and gK mutations
enhanced spread through the HEp-2 cell monolayer by cell fusion. Because extreme selective pressure was required to
favor these mutations and such mutations are rare in clinical isolates, the wild-type forms of gC and gK must provide for
optimal viral replication and propagation in cell culture as well as in vivo, despite the view that gC is dispensable in cultured
cells. q 1996 Academic Press, Inc.
INTRODUCTION more efficient binding of HSV-1 to HEp-2 cells than gB
alone, gC is dispensable for viral penetration while gB
Entry of herpes simplex virus (HSV) into cells is a com- is essential (Heine et al., 1974; Manservigi et al., 1977;
plex process involving multiple viral and cellular compo- Sarmiento et al., 1979; Cai et al., 1988). In addition to its
nents. Although humans are the only known natural host role in virus binding to cells, gC can also bind to various
for HSV, the virus is able to infect a variety of animals forms of C3 and can modulate complement activation
and many cultured cell types derived from numerous (Dubin et al., 1992).
vertebrate species (Corey and Spear, 1986). This diver- Binding of virus to cells becomes resistant to elution
sity of susceptible cells suggests either that the virus is by heparin over time, implying that virus attachment to
capable of utilizing highly conserved cellular compo- heparan sulfate becomes stronger or leads to interaction
nents to effect entry or that more than one entry pathway with other cell surface constituents (Fuller and Lee, 1992;
exists. Karger and Mettenleiter, 1993). After binding, subsequent
Initial attachment of HSV is to cell surface glycosami- penetration of virus proceeds by fusion of the viral enve-
noglycans, principally heparan sulfate (Vaheri and Can- lope with the cell membrane (Morgan et al., 1968; Para
tell, 1963; WuDunn and Spear, 1989; Shieh et al., 1992; et al., 1980; Fuller and Spear, 1987; Wittels and Spear,
Gruenheid et al., 1993). This attachment is inhibited by 1990). Several essential viral glycoproteins, including gB,
soluble heparin (WuDunn and Spear, 1989; Shieh et al., gD (US6), gH (UL22), and gL (UL1), and possibly the
1992), a glycosaminoglycan that is closely related to he- tegument protein UL25, are required for penetration (Cai
paran sulfate, although more highly sulfated, and is often et al., 1988; Addison et al., 1984; Ligas and Johnson,
used as a substitute for heparan sulfate in functional 1988; Forrester et al., 1992; Roop et al., 1993).
studies (Jackson et al., 1991). For HSV-1, either of two Spread of virus infection in vivo can occur via infec-
viral glycoproteins, gC (UL44) or gB (UL27), can mediate tious virus or by virus-induced cell fusion. Syncytia, pre-
the binding of virus to cell surface heparan sulfate (Her- sumably resulting from HSV-induced cell fusion, are a
old et al., 1991, 1994). Although gC alone can mediate hallmark of herpetic lesions in vivo though wild-type
strains of HSV usually do not induce syncytium formation
in cultured cells (Spear, 1993). Nonlethal mutations in1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (312) 503-1339; E-mail: p-spear@nwu.edu. any one of several HSV-1 genes, including UL20, UL24,
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gB, and gK (UL53), yield syncytium-forming mutants (Bzik MATERIALS AND METHODS
et al., 1984; Cai et al., 1988; Debroy et al., 1985; Pogue-
Cells and virusesGeile and Spear, 1987; Baines et al., 1991; Sanders et
al., 1982; Jacobson et al., 1989; Weise et al., 1987; Good- Vero and HEp-2 cells were obtained from American
man and Engel, 1991; Gage et al., 1993; Dolter et al., Type Culture Collection. VeroB24 cells carry a functional
1994; DeLuca et al., 1982). HSV-1(F) gB gene (Herold et al., 1991) and were used to
HSV-1 entry and HSV-1-induced cell fusion both de- propagate gB-negative virus. Vero cells were passaged
pend upon virus-induced membrane fusion and require in medium 199 supplemented with 5% fetal bovine serum.
overlapping sets of viral and cell factors, including HSV- HEp-2 and VeroB24 cells were passaged in Dulbecco’s
1 gB, gD, gH, and gL and the presence of cell surface modified Eagle’s medium (DME) supplemented with 10%
glycosaminoglycans (Cai et al., 1988; Ligas and Johnson, fetal bovine serum. HSV-1(KOS), designated KOS in this
1988; WuDunn and Spear, 1989; Forrester et al., 1992; paper, was provided by P. Schaffer, Harvard Medical
Roop et al., 1993; Shieh and Spear, 1994; Shieh et al., School. HSV-1(MP), designated MP, has a mutation in
1992; Davis-Poynter et al., 1994). The tegument protein gK conferring a syncytial phenotype (Pogue-Geile and
encoded by UL25 may be required for viral entry (Addison Spear, 1987; Hoggan and Roizman, 1959). HSV-
et al., 1984), but it is not known whether it is required for 1(KOS)DgC6 (Visalli, 1992) and HSV-1(KOS)DgC2-3 (Her-
old et al., 1994), designated DgC6 and DgC2-3, respec-cell fusion. While HSV-1 gC enhances viral entry, it is not
tively, are gC-negative strains obtained from C. Brandt,required for syncytium formation and in fact appears to
University of Wisconsin. Both strains have the Esche-inhibit the fusion of some cultured cells (Manservigi et
richia coli lacZ gene replacing the majority of the gCal., 1977; Novotny et al., 1996), perhaps accounting for
opening reading frame. DgC6 was purified from thethe absence of gC expression by many syncytial mutants
same pool of recombinants as DgC2-3 (Visalli, 1992).(Spear, 1993). On the other hand, the membrane-associ-
HSV-1(KOS)DgC6REV, designated DgC6REV, is a re-ated product of the UL45 gene is required for syncytium
vertant ofDgC6 obtained by replacing the lacZ gene withformation but not for viral entry (Visalli and Brandt, 1991;
the wild-type gC gene (Visalli, 1992). HSV-1(KOS)KO82,Haanes et al., 1994). Other viral glycoproteins, including
designated KO82, is a gB-negative virus provided by S.gE (US8), gI (US7), and gM (UL10), may also enhance
Person, Johns Hopkins University (Cai et al., 1988).syncytium formation (Davis-Poynter et al., 1994), perhaps
by altering the synthesis or processing of fusogenic viral
Viral plaque assaysglycoproteins, but are not required for viral entry. Thus,
viral penetration and viral-induced cell fusion are similar
Viral plaque assays were performed on Vero or HEp-
in their requirements for gB, gD, gH, and gL but differ in
2 cells (Herold et al., 1991). Either 25-cm2 flasks or six-
requirements for other viral gene products. well dishes were inoculated for 1 to 2 hr at 377 with virus
The purpose of this study was to isolate mutants of diluted in complete phosphate-buffered saline (PBS). The
HSV that are resistant to the inhibitory effects of heparin inoculum was subsequently removed and the cells were
on binding and penetration and, therefore, might use overlaid with medium 199 supplemented with 1% heat-
altered entry pathways. To this end, wild-type HSV-1 inactivated newborn calf serum and 0.1% pooled human
strain KOS was serially passaged in the presence of gamma globulin (Armour) (199O). In some experiments
soluble heparin during the entry phase. Since either gB or cyclosporin A (Sandoz), dissolved in dimethyl sulfoxide
gC can mediate binding of virus to cell surface heparan (DMSO), or melittin (Sigma) was added to the 199O at
sulfate and both bind to heparin (Herold et al., 1991, 100 or 1 mM, respectively (McKenzie et al., 1987; Baghian
1994), alterations in one or both of these glycoproteins and Kousoulas, 1993). After 2 to 3 days of incubation at
might result under these conditions. When the uncloned 377 in 5% CO2 , plaques were counted. Plaques were
pools of virus obtained under these conditions were ana- visualized by either fixing the cells and then staining
lyzed, more than 58% of the virus no longer expressed with Giemsa or by one of two immunoassays. The most
gC and, consistent with a previous report (Goodman and frequently used immunoassay was modified from one
Engel, 1991), more than 95% were syncytium forming. developed by Holland and co-workers (Holland et al.,
Subsequent experiments showed that the absence of gC 1983; Herold et al., 1991). Briefly, cell monolayers were
conferred an advantage for binding and penetration in washed with PBS and then fixed with methanol. The cells
the presence of heparin, thus explaining the enrichment were incubated with PBS containing 2% bovine serum
for gC-negative mutants. Given that deletion of gC re- albumin (BSA; Sigma) and then sequentially with one or
duces the infectivity of HSV-1 in the absence of heparin more monoclonal antibodies (mAbs) directed against vi-
(Herold et al., 1991, 1994), combination of the gC and ral glycoproteins, biotinylated goat anti-mouse immuno-
syncytial mutations could have provided the mutants with globulin G (Gibco BRL or Sigma; diluted 1:300), and strep-
a selective advantage by enhancing spread through the tavidin-b-galactosidase conjugate (Gibco BRL or Sigma;
diluted 1:300). Plaques turned blue after the addition ofHEp-2 cell monolayer by cell fusion.
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X-gal substrate (X-gal [Sigma] dissolved in DMSO and Purification of viral DNA
subsequently diluted to 0.5 mg/ml in ferricyanide buffer
A technique modified from protocols described pre-[3 mM K3Fe(CN)6 , 3.125 mM K4Fe(CN)6]). mAbs used in-
viously was used to purify viral DNA (Mettenleiter et al.,cluded the anti-gB antibody II-105 (diluted 1:1000) and
1988; Ben-Porat et al., 1976). Infected HEp-2 cells werethe three anti-gC antibodies II-474, II-512, and VII-13-
incubated until complete cytopathic effect (CPE) was7 (diluted 1:1000). All antibodies have previously been
noted. After centrifugation at 750 g for 20 min to removedescribed (Para et al., 1985; Novotny et al., 1996). For
the cells, virus was pelleted from the supernatant byassessing gC expression, cells were fixed with methanol
centrifuging at 75,000 g for 1 hr and then resuspendedand then incubated with a mix of anti-gC antibodies fol-
in TE buffer (10 mM Tris–HCl [pH 7.4], 1 mM EDTA)lowed by biotinylated goat anti-mouse immunoglobulin
containing 150 mM NaCl (TEN). Additional virus was re-G and streptavidin horseradish peroxidase conjugate
leased from the cells by dounce homogenization and,(Gibco BRL; diluted 1:300). Plaques turned black after
after centrifuging at 2000 g for 15 min to remove thethe addition of peroxidase substrate (0.003% hydrogen
cellular debris, combined with the virus resuspended inperoxidase, 0.01% 4-chloro-1-napthol [diluted from a 1%
TEN. A three-step sucrose gradient centrifuged for 1 hrstock solution dissolved in ethanol]). To obtain the total
at 90,000 g was used to purify the virus, which was sub-plaque number, the infected cultures were subsequently
sequently diluted with TEN, pelleted, and resuspendedcounterstained with either Giemsa for Vero cells or the
in TEN. All centrifugation was at 47 in a LS-50 ultracentri-above immunoassay using anti-gB antibody and streptav-
fuge or TJ-6 centrifuge (Beckman). Virus was then se-
idin-b-galactosidase conjugate for HEp-2 cells. Cells
quentially incubated with sarcosyl buffer (75 mM Tris–
were not fixed for immunoassays done during plaque
HCl [pH 7.4], 25 mM EDTA, 3% sodium sarcosinate) at
purification of virus. An alternative immunoassay utilized
657 for 20 min, RNase (Sigma) at 377 for 30 min, and
the human antibody contained in the 199O. Briefly, cells
proteinase K (Boehringer Mannheim) at 427 for 2 hr. The
were washed with PBS, fixed with 8% paraformaldehyde
resulting viral DNA was phenol–chloroform extracted,
diluted in 100 mM lysine phosphate buffer (200 mM ly-
precipitated with sodium acetate and ethanol, and resus-
sine–HCl buffered to pH 7.4 with 100 mM Na2HPO4 and pended in TE buffer, pH 8.0.
then diluted to 100 mM by the addition of 100 mM
NaH2PO4 [pH 7.4]), and then incubated with anti-human Amplification of viral DNA sequences
horseradish peroxidase conjugate (Gibco BRL; diluted
1:250). Plaques were visualized after the addition of per- Polymerase chain reaction (PCR) was performed using
oxidase substrate. Vent polymerase (New England Biolabs) and purified vi-
ral DNA was isolated as described above. The gK gene
along with flanking sequences was amplified using the
Viral binding and penetration assays
sense primer gK-2 5*-GGTCCTCCTACAGCTAGTCC-3*
and the anti-sense primer gK-1 5*-ACAAGGACCAAT-
Virus was diluted in PBS in the presence or absence
CAGACACC-3*. All primers were made by the Northwest-
of heparin (Sigma) and then inoculated onto 25-cm2
ern University Biotechnology Facility. The reaction solu-
flasks of HEp-2 cells for 2 hr at 377. After the inoculum tion consisted of 10 to 100 ng of viral DNA, 100 pmol of
was removed, the cells were treated either with PBS or each primer, 10 mM KCl, 10 mM (NH4)2SO4 , 20 mM Tris–with citrate buffer (40 mM citric acid, 10 mM KCl, 135 HCl [pH 8.8], 2 mM MgSO4 , 0.1% Triton X-100, 10 mg BSA,mM NaCl [pH 3.0]) to inactivate any bound but unpene- 2 units of polymerase, and 5% DMSO or 5% formamide.
trated virus (Highlander et al., 1987; Huang and Wagner, Thermocycling reactions using a PTC-100 programmable
1964). The cells were subsequently washed three times thermal controller (MJ Research) consisted of 30 cycles
with PBS and then overlaid with medium 199 supple- of 90 sec at 957, 60 sec at 577, and 90 sec at 727. A final
mented with 1% heat-inactivated newborn calf serum extension for 5 min at 727 followed. All PCR products
(199V) containing 0.5% methylcellulose to prevent spread were desalted and concentrated using the QIAEX II gel
of free virions yet not inactivate bound but unpenetrated extraction kit (Qiagen). The concentration of the DNA
virus. After incubation for 3 days at 377 in 5% CO2 , was calculated using a DU 640 spectrophotometer
plaques were visualized using an anti-gB immunoassay. (Beckman).
Plaques obtained on cells not treated with citrate buffer
represented viral binding because unbound virus was Marker transfer experiments
removed by the PBS washes and the time for subsequent
penetration of bound virus was limited only by the spon- Transfections into Vero cells were done using Lipofec-
taneous inactivation rate of virus. In contrast, plaques on tamine Reagent (Gibco BRL). Briefly, purified KOS DNA
cells treated with citrate buffer represented viral penetra- and 1 to 2 mg of PCR product containing the gene of
tion since unpenetrated virus was inactivated by the acid interest were incubated with Lipofectamine Reagent in
Opti-MEM (Gibco BRL), without added serum or antibiot-wash.
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ics, for 30 min at room temperature. The ratio of viral was confirmed by staining the nitrocellulose blot with
Ponceau S. The nitrocellulose blot was incubated inDNA to PCR product was 1:6 based on weight. Subcon-
fluent Vero cells in six-well dishes were rinsed with PBS blocking buffer (150 mM NaCl, 10 mM Tris–HCl [pH 7.4],
0.2% Tween 20, 0.02% thimerosal, and 5% milk) overnightand subsequently overlaid with the DNA–Lipofectamine
mixture and incubated at 377 for 6 to 8 hr. The transfection at 47 and then sequentially with polyclonal rabbit antise-
rum (diluted 1:1000) and alkaline phosphatase-conju-mixture was removed, DME containing 1% heat-inacti-
vated newborn calf serum along with antibiotics was gated anti-rabbit immunoglobulin G (Sigma; diluted
1:6000). Reactive bands were visualized after incubationadded, and the cells were incubated for 48 hr at 377 in
5% CO2 . The cells were subsequently harvested and with chemiluminescence ECL substrate (Amersham) and
subsequent exposure to autoradiography film (Kodak).lysed for the titration of infectious progeny on Vero cells.
Rabbit anti-gB antibody R-74 and anti-gC antibody R-77
Construction of recombinant virus were used. R-74 has been previously described (Herold
et al., 1994). R-74 and R-77 were preabsorbed by incuba-Recombinant virus was constructed either by transfect-
tion at 47 overnight with a KO82-infected cell lysate anding the gene of interest along with viral DNA into Vero
a DgC2-3-infected cell lysate, respectively.cells as described above or by allowing two viruses to
generate recombinants after infecting cells. For the latter
Statistical analysismethod, Vero cells were infected with each virus of inter-
est at a multiplicity of infection (m.o.i.) of 1.0 plaque-form- Mann–Whitney rank sum tests were used to compare
ing units (PFU)/cell. After complete CPE was noted, the median values. Proportional differences were analyzed
cells were harvested and freeze–thawed. For both meth- using compare proportions. All statistics were performed
ods, recombinants that displayed the desired phenotypes using SigmaStat Version 1.00 (Jandel).
were plaque-purified and then stocks were prepared after
passage on HEp-2 cells. Both plaque immunoassays and RESULTS
detection of b-galactosidase activity were used to verify
gC-negative and gC-positive phenotypes. Virus express- HSV mutants selected by passage in soluble heparin
ing b-galactosidase was detected by incubating infected
To select for mutants capable of binding and penetrat-cells with X-gal dissolved in DMSO at 0.5 mg/ml and fer-
ing in the presence of heparin, KOS was inoculated ontoricyanide buffer at 377.
75-cm2 flasks of HEp-2 cells in the presence of heparin
at a concentration of either 10 or 1000 mg/ml. SufficientNucleotide sequencing
virus was added to achieve an effective multiplicity of
Nucleotide sequences were determined directly from 0.01 PFU/cell, taking into account the heparin inhibition
PCR products using the fmol DNA sequencing system of infectivity. After incubation for 2 hr at 377 to allow viral
(Promega) which utilizes thermocycling and 32P-end-la- binding and penetration, the inoculum was removed and
beled primers. Both strands were sequenced once and the cell monolayer was treated with citrate buffer (pH
the sequence was confirmed by analyzing at least one 3.0) to inactivate any bound but unpenetrated virus. The
strand from another PCR product obtained indepen- infected cells were rinsed, overlaid with 199V, and then
dently. The six primers used were designed by Dolter incubated without heparin at 377 in 5% CO2 until signifi-
and coworkers (1994). The three sense primers were gK- cant CPE was noted. After spinning down the cellular
17 5*-CGCCAAATGCGACAGCAACC-3*, gK-19 5*-ATC- debris, virus was pelleted from the medium by centrifug-
GTCGGATCATGAACG-3*, and gK-22 5*-GTCATCGTA- ing at 75,000 g for 1 hr at 47. Pelleted virus was resus-
GGCTGCGAG-3*. The three anti-sense primers were pended in 199V and subsequently inoculated onto HEp-
gK-36 5*-TATGCCGTTCCGGTTTCCGC-3*, gK-26 5*-CGG- 2 cells as described above. Heparin was added for the
TGCCGACGATGAGACCC-3*, and gK-35 5*-CCAGAC- 2-hr inoculation period and citrate buffer was used to
GCACCCGTGTGTAC-3*. Reactions were electropho- inactivate unpenetrated virus at the end of the inoculation
resed on a 6% polyacrylamide gel (FMC BioProducts). period during each passage. Four pools were obtained
by independently and serially passaging virus 20 times:
Western blots
pools A and B with heparin at 10 mg/ml and pools C and
D with heparin at 1000 mg/ml.Lysates of HEp-2 cells infected with virus were solubi-
lized in sodium dodecyl sulfate (SDS) sample buffer, Selecting for virus that could bind and penetrate in
the presence of heparin resulted in enrichment for gC-boiled for 2 min, and then loaded onto a 12% SDS–poly-
acrylamide gel (N,N *-methylene-bis-acrylamide) (Bio- negative syncytial mutants. Almost all virus from the four
pools had a syncytial phenotype when plated on HEp-2Rad Laboratories). Following electrophoresis, the pro-
teins were transferred to nitrocellulose (Schleicher & cells (Table 1) or Vero cells (Table 2). Because many
syncytial strains of HSV do not express gC (Spear, 1993),Schuell) using a semidry method for subsequent Western
blotting (Kyhse-Anerson, 1984). Transfer of the proteins plaques were scored for gC expression by an immunoas-
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TABLE 1 HS2, HS3, and HS4 (Table 2). Although melittin altered
the plaque morphology for HS1, the plaques remainedPhenotypes of Uncloned Progeny in the Heparin-Selected Pools
syncytial. These data suggested that the syncytial muta-
Percentage of plaques with each tion was in gK for HS2, HS3, and HS4. By plating the
phenotype (range)a uncloned virus pools in the presence and absence of
melittin, we found that the syncytial phenotype was inhib-
Virus gC-negative Syncytial
ited by melittin for most viruses in the pools (Table 2).
This suggested that most of the syncytial mutants haveKOS 0.3 (0 –0.3) 0
Pool A 66 (66–67) 99 (98–99) a mutation in gK.
Pool B 58 (56–59) 99 (93–99) Marker-transfer experiments were performed using
Pool C 86 (82–90) 99 (96–100) the gK genes amplified by PCR from all four heparin-
Pool D 79 (74–83) 98 (97–100)
selected mutants (Table 3). The syncytial phenotype
could be transferred to the wild-type background by thea Plaques obtained after infecting HEp-2 cells with virus were scored
for syncytia and expression of gC using immunoassays described in gK genes from all four heparin-selected mutants,
the text. Percentages represent the median of three separate experi- whereas no such transfer was observed using the gK
ments each done in duplicate. Approximately 400 to 2000 plaques were gene from KOS. In three of four cases, the number of
scored for KOS and each pool. Differences between the percentage of
syncytial recombinants differed significantly from theeach pool with a given phenotype and KOS were statistically significant
negative value obtained for KOS. The observation that(P  0.05; Mann–Whitney rank sum test).
melittin failed to inhibit syncytium formation induced by
HS1 implies that a second syncytial mutation may be
say using a pool of three anti-gC mAbs. A pool of mAbs present or that the altered form of gK was not affected
was used to increase the chances of detecting altered by the melittin.
forms of gC. Plaques were counterstained by an immuno- Sequencing of the gK open reading frames revealed
assay using a mAb directed against gB, an essential that all four heparin-selected mutants had a mutation at
glycoprotein. Approximately 60 to 85% of the virus in the nucleotide position 119 (C to T) that resulted in a pre-
pools did not express gC (Table 1). dicted conservative amino acid substitution of valine for
To facilitate characterization of the mutants present in alanine (Fig. 1). This amino acid substitution has pre-
the virus pools, four mutants were plaque-purified from viously been shown to be sufficient to induce syncytium
pools A and C and designated HSV-1(KOS)HS for hepa- formation (Pogue-Geile and Spear, 1987; Dolter et al.,
rin-selected. HS1 and HS3 were gC-negative while HS2 1994). The nucleotide change of interest resulted in the
and HS4 were gC-positive. All four heparin-selected mu-
tants had a syncytial phenotype on HEp-2 and Vero cells
(Table 2 and data not shown). TABLE 2
Effect of Melittin on Syncytial Plaque MorphologyMapping of the syncytial mutations
Percentage of plaques with syncytialMapping the mutations responsible for the syncytial
phenotype (range)aphenotype was facilitated by using two inhibitors of HSV-
Virusinduced syncytium formation to screen the heparin-se-
stock No melittin Melittin
lected mutants (Baghian and Kousoulas, 1993; Walev et
al., 1994; McKenzie et al., 1987; Walev et al., 1991). Pool A 98 (97–100) 5 (3–24)
Pool B 94 (91–94) 0.4 (0–0.5)Cyclosporin A inhibits syncytium formation if the respon-
Pool C 96 (90–100) 0 (0–5)sible mutation is not in the cytoplasmic tail of gB (Walev
Pool D 97 (96–98) 1 (0–14)et al., 1994). When titered in the presence of cyclosporin
HS1 100 99 (98–100)
A, the infectivity of all four heparin-selected mutants was HS2 100 0
reduced by approximately 50% and the plaque morphol- HS3 100 0
HS4 100 0ogy changed from syncytial to nonsyncytial for HS2, HS3,
and HS4 while the results for HS1 were equivocal (data
a Vero cells were incubated with virus diluted in PBS for 1 hr at 377.not shown). These data implied that the mutation respon-
After removal of the inoculum, the monolayers were overlaid with 199O
sible for the syncytial phenotypes of HS2, HS3, and HS4 with or without added melittin at 1 mM, incubated for 2 days at 377 in
was not in the cytoplasmic tail of gB. Melittin, a bee 5% CO2 , and then stained with Giemsa. Percentages represent the
median of three separate experiments each done in duplicate. Differ-venom that blocks the Na//K/ ATPase, inhibits syncytium
ences between the percentages of syncytial plaques for pools A, B, C,formation if the responsible mutation maps to gK (Bag-
and D in the presence or absence of melittin were statistically signifi-hian and Kousoulas, 1993). When titered in the presence
cant (P  0.05; Mann–Whitney rank sum test). Differences between
of melittin, the infectivity of all four heparin-selected mu- the percentages of syncytial plaques for HS2, HS3, and HS4 in the
tants was reduced approximately 50% and the plaque presence or absence of melittin were statistically significant (P  0.05)
while the difference for HS1 was not (P  0.1).morphology changed from syncytial to nonsyncytial for
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TABLE 3 cloned mutants and, according to the results obtained
using melittin, was probably present in 90 to 95% of theMapping of Syncytial Mutation to gK by Marker Transfer a
virus in all four pools, but was not present at detectable
Number of levels in the original KOS stock.
Virus donating Number of syncytial plaques
gK plaques scored (percentage) Resistance to heparin inhibition
KOS 4095 0 The purpose of subsequent experiments was to deter-
MP 3186 23 (0.7) mine the relative contributions of mutations in gC and
HS1 3478 10 (0.3)
gK to resistance to heparin inhibition. To determineHS2 3453 3 (0.09)
whether the heparin-selected mutants or those in theHS3 4009 12 (0.3)
virus pools were relatively resistant to heparin inhibitionHS4 4739 15 (0.3)
of infectivity, KOS and the cloned or uncloned mutants
a Genomic DNA from KOS was cotransfected with PCR-amplified gK were plated in the absence and presence of heparin to
genes from each of the four heparin-selected mutants. The gK genes
determine percentage of virus that could form plaquesfrom MP and KOS were used as positive and negative controls, respec-
in the presence of heparin, relative to KOS (Table 4). Thetively. Progeny from the transfected cells were plated on Vero cells
two gC-negative mutants, HS1 and HS3, were approxi-for quantitation of the relative numbers of syncytial and nonsyncytial
plaques. The results obtained in three different independent experi- mately 10- to 20-fold more resistant to heparin inhibition
ments (done with progeny from separate transfections and PCR amplifi- than KOS while the two gC-positive mutants, HS2 and
cations) were pooled. Differences between the percentages of syncytial
HS4, were only minimally resistant. For the gC-negativeplaques obtained after transfection with the gK genes from MP, HS1,
mutants the level of resistance did not differ significantlyHS3, and HS4 and the percentages after transfection of gK from KOS
from that noted for gC-negative recombinants that werewere statistically significant (P  0.001, P  0.002, P  0.001, and P
 0.001, respectively; compare proportions). The difference between not selected in heparin, DgC6 (Table 4) and DgC2-3
KOS and HS2 was not statistically significant (P  0.191). (data not shown). These recombinants were constructed
by replacing the majority of the gC open reading frame
with the E. coli lacZ gene (Visalli, 1992). A revertant virus,
DgC6REV, in which the gC deletion of DgC6 was re-loss of a BstUI endonuclease site and the gain of a BsaAI
paired, did not differ significantly from KOS. Thus, losssite. This mutation was confirmed by restriction digest
of gC expression appeared to be sufficient to explain theanalysis of gK genes amplified by PCR from all four mu-
relative resistance to heparin inhibition noted for HS1tants. Digestion with these endonucleases (New England
and HS3. For the gC-positive mutants, there may haveBiolabs) resulted in the expected fragment patterns after
been an alteration in gC or a mutation in another glyco-electrophoresis on an agarose gel (data not shown).
protein, such as gB, that conferred slightly enhancedTwo additional predicted amino acid substitutions
resistance to heparin inhibition. The populations of viruswere noted. A threonine to methionine substitution re-
in the pools exhibited resistance to heparin inhibitionsulted from a mutation at nucleotide position 302 (C to
that varied from 2- to 15-fold when compared to KOST) in HS1, HS2, and HS4, and an alanine to threonine
(Table 4). Interestingly, the degree of resistance to hepa-substitution resulted from a mutation at position 496 (G
rin inhibition did not correlate in a simple way with theto A) in HS4. Multiple silent mutations were also found
absence of gC expression in the virus pools (Tables 1in HS1, HS2, and HS4. Interestingly, all the changes in
and 4).HS1 and HS2 were identical. One possible explanation
is that both the gC-negative HS1 and the gC-positive HS2
Construction of recombinant viruses
arose from a common precursor that was first altered in
the gK gene. HS1 then subsequently lost the ability to To define the contribution of the altered form of gK to
express gC. Many of the silent and nonsilent nucleotide selection of the heparin-resistant mutants, the HS3-gK
substitutions found in the mutants are present in MP (Fig. gene was transferred to KOS and DgC6 backgrounds.
1). Although the gK genes isolated from three of the four The HS3-gK gene was used because it differed from the
heparin-selected mutants resembled that of MP more KOS-gK gene only at amino acid position 40. The gC-
than that of KOS, none of these genes was identical positive syncytial recombinant was plaque-purified from
to that of MP. The possibility exists that recombination a cell lysate generated during the marker-transfer experi-
between KOS and a low level of contaminating MP oc- ments described above and was named SyngK. The gC-
curred during selection of the virus pools. An alternative negative recombinant was plaque-purified from a cell
possibility is that these mutations, although predicted to lysate obtained by co-infecting cells with SyngK and
be mostly silent, may have conferred a selective advan- DgC6 and was named DgC6syngK. Plaque immunoas-
tage to the mutants. Whatever the source of the nucleo- says and b-galactosidase activity along with restriction
tide substitutions, however, there was strong selection digests of the gK genes amplified by PCR were used to
confirm that SyngK was gC-positive, that DgC6syngKfor the syncytial mutation since it was found in all four
AID VY 8252 / 6a25$$$303 10-31-96 14:17:26 vira AP: Virology
28 PERTEL AND SPEAR
AID VY 8252 / 6a25$$8252 10-31-96 14:17:26 vira AP: Virology
29ENTRY AND SYNCYTIUM FORMATION BY HSV
TABLE 4 plaque-purifying nonsyncytial virus. Plaque immunoas-
says along with restriction digests of the gK gene ampli-Effect of Heparin on Plaquing Efficiency
fied by PCR were used to confirm that SyngKREV was
Relative resistance to inhibition gC-positive, was nonsyncytial, and carried the wild-type
by heparina allele of gK (data not shown).
Virus 10 mg/ml 1000 mg/ml Effect of heparin on binding and penetration
KOS (gC-positive) 1 1 To assess the relative effects of heparin on binding
Pool A 2 2 and penetration of viruses altered in gC and/or gK, HEp-
Pool B 15 9 2 cells were inoculated with KOS, HS3, DgC6, SyngK, or
Pool C 2 3
DgC6syngK in the absence or presence of heparin atPool D 15 5
100 mg/ml. Preliminary data showed no significant differ-HS1 (gC-negative) 15 8
HS2 (gC-positive) 2 3 ences between the results obtained with 10 or 1000 mg/
HS3 (gC-negative) 17 15 ml heparin. Thus, an intermediate dose was used to sim-
HS4 (gC-positive) 4 6 plify the experiments. After incubation for 2 hr to allow
DgC6 (gC-negative) 14 25
virus binding and entry, the cells were washed with PBSDg6REV (gC-positive) 2 1
to remove unbound virus or were treated with low pH
a Plaque assays were performed by inoculating HEp-2 cells with citrate buffer to inactivate bound but unpenetrated virus.
virus diluted in PBS in the absence or presence of heparin (10 or The latter condition (treatment with citrate buffer) was
1000 mg/ml). Three experiments each done in duplicate were per- similar to that used during selection of the mutant virus
formed. The number of plaques obtained in the presence of heparin
pools.was expressed as a percentage of the number detected in the ab-
The results are presented in two different ways in Figs.sence of heparin. Results are presented as the median of the ratios
of this percentage obtained for each virus compared to the percent- 2 and 3. Figure 2 shows the number of plaques formed
age obtained for KOS. Percentages for KOS in the presence of 10 and in the presence of heparin as a percentage of the number
1000 mg/ml heparin were approximately 0.1 and 0.03, respectively. in the absence of heparin. On the left, both the heparin-
Differences in the ratios obtained between KOS and pool B, pool C,
treated and control cultures were washed with PBS, sopool D, HS1, HS3, HS4, and DgC6 in the presence of 10 and 1000
that the percentages shown indicate the relative abilitiesmg/ml heparin were statistically significant (P 0.05; Mann – Whitney
rank sum test). Differences between KOS and pool A and HS2 in of each virus strain to bind to cells in the presence and
the presence of 1000 mg/ml heparin were also statistically significant absence of heparin. On the right, the heparin-treated cul-
(P  0.05) while differences with 10 mg/ml were not (P  0.1). Differ- tures were also treated with citrate buffer, whereas the
ences between KOS and DgC6REV in the presence of 10 mg or 1000
control cultures were washed only with PBS, so that themg/ml heparin were not statistically significant (P  0.1 and P 
percentages indicate the cumulative inhibitory effects of0.35, respectively). Differences between DgC6 and HS2, HS4, and
DgC6REV in the presence of 10 and 1000 mg/ml heparin were statis- heparin on binding and penetration. Figure 3 shows the
tically significant (P  0.05). Differences between DgC6 and HS1 fraction of bound virus that penetrated within 2 hr
or HS3 in the presence of 10 mg/ml (P  0.5) and 1000 mg/ml (P (plaques after citrate treatment as a percentage of PBS 0.1 and P  0.2, respectively) of heparin were not statistically
controls) in the absence or presence of heparin.different.
Several findings emerge from these data. First, al-
though the major effect of heparin was to inhibit the
binding of virus to cells, as expected, heparin also inhib-was gC-negative and expressed b-galactosidase, and
that both viruses carried the mutated allele of gK (data ited or delayed viral penetration for all strains tested (Fig.
3). The gC-negative strains were least sensitive to thenot shown). Because the syncytial mutation in the gK
allele results in the loss and the gain of restriction en- inhibitory effects of heparin on virus penetration. Second,
the gC-negative strains were least sensitive to the cumu-zyme sites, digestion with both enzymes allowed confir-
mation that the desired recombination had actually oc- lative inhibitory effects of heparin on binding and pene-
tration (Fig. 2). Thus, under the selective conditions used,curred. The revertant for SyngK, designated SyngKREV,
was constructed by transfecting the KOS-gK gene and any one of the gC-negative strains was almost 10 times
more resistant than KOS to the inhibitory effects of hepa-genomic SyngK DNA into Vero cells and subsequently
FIG. 1. Nucleotide and protein sequences for the gK open reading frames from KOS, MP, and the four heparin-selected mutants. Nucleotide
numbering starts at the beginning of the gK open reading frame. The gK open reading frame from KOS was sequenced as a control, yielding the
same results as those previously published (Debroy et al., 1985). The sequence for MP gK was obtained from published reports (Debroy et al.,
1985; Pogue-Geile and Spear, 1987). The nucleotides in positions 245 and 246 of MP gK have been reported as both CG and GC. Shown are the
predicted amino acid substitutions for each heparin-selected mutant and MP above the protein sequence for KOS. Predicted N-linked glycosylation
sites (double overline), hydrophobic domains (single overline), and signal peptidase cleavage site (arrow) are also shown (Pogue-Geile and Spear,
1987). The HS1, HS2, HS3, and HS4 gK nucleotide sequences were deposited with GenBank (Accession Nos. U67870, U67871, U67872, and U67873,
respectively).
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cantly from KOS in terms of the ability to bind to cells in
the presence of heparin and the fraction of bound virus
that penetrated in the absence or presence of heparin
(data not shown). In comparing the cumulative inhibitory
effects of heparin on binding and penetration, SyngKREV
also did not differ significantly from KOS, whereas
DgC6REV differed marginally but gave values clearly
overlapping KOS values and different from DgC6 values
(data not shown).
Cell dependence of HS3-gK-induced syncytium
formation
Previous studies have shown that syncytium formation
on HEp-2 cells induced by mutations in gK is associated
with lack of gC expression (Manservigi et al., 1977; Ruye-
chan et al., 1979; Pogue-Geile et al., 1984). Plaques
formed by the gC-positive syncytial recombinant SyngK
on Vero and HEp-2 cells had a syncytial and nonsyncytial
morphology, respectively (data not shown). In contrast,
plaques formed by the gC-negative syncytial recombi-
FIG. 2. Effects of heparin on binding to cells and penetration of the
virus strains indicated. Virus was diluted in PBS in the absence or
presence of soluble heparin (100 mg/ml) and added to HEp-2 cells for
the initial absorption period of 2 hr. At the end of 2 hr, the cells were
washed with PBS and overlaid with 199V containing methylcellulose
to determine the relative amounts of virus bound in the presence and
absence of heparin, as assessed by plaque formation (left). Alterna-
tively, the cells were treated with citrate buffer, washed with PBS, and
overlaid with 199V containing methylcellulose to determine the relative
amounts of virus that had penetrated by 2 hr in the presence of heparin
(right). Three different experiments each done in duplicate were per-
formed. Shown on a logarithmic scale are the geometric means and
the standard deviations. Differences in the effects of heparin on binding
between KOS and HS3, DgC6, and DgC6syngK were all statistically
significant (P  0.05; Mann–Whitney rank sum test). Differences be-
tween KOS and SyngK (P  0.35) and between HS3 and DgC6 or
DgC6syngK (P  0.35 and P  0.5, respectively) were not statistically
significant. Differences in the effects of heparin on penetration between
KOS and HS3, DgC6, SyngK, and DgC6syngK were all statistically
significant (P  0.05). Differences between HS3 and DgC6 or
DgC6syngK were not statistically significant (P  0.5 and P  0.35,
respectively). The difference between HS3 and SyngK was statistically
significant (P  0.05). Results similar to DgC6 were also obtained with
a second gC-negative recombinant, DgC2-3 (data not shown).
FIG. 3. Effects of heparin on penetration of bound virus. Data fromrin on infectivity. Third, SyngK was even more sensitive
the experiment described in Fig. 2 were recalculated to show, for the
than KOS to the inhibitory effects of heparin on penetra- virus strains indicated, the percentage of bound virus that had pene-
tion. Although the explanation for this enhanced sensitiv- trated by 2 hr in the absence and presence of heparin. Penetration of
bound virus was calculated as the number of plaques obtained onity is not known, the result defines a previously unde-
citrate-treated cells as a percentage of the number obtained on cellsscribed phenotype for gK syncytial mutations. Finally,
not treated with citrate. Shown on a linear scale are the means andresistance to heparin inhibition conferred by the gC-neg-
the standard deviations. In the absence of added heparin (left), differ-
ative mutation was dominant over enhanced sensitivity ences in penetration for KOS and HS3, DgC6, SyngK, or DgC6syngK
conferred by the gK syncytial mutation. Because the gC- were not statistically significant (P  0.5, P  0.5, P  0.35, and P 
0.2, respectively; Mann–Whitney rank sum test). In the presence ofpositive heparin-selected syncytial mutants were rela-
added heparin (right), differences in penetration for KOS and HS3,tively resistant to heparin inhibition, it seems likely that
DgC6, SyngK, and DgC6syngK were all statistically significant (P these mutants express an altered form of gC or have
0.05). Differences between HS3 and DgC6 or DgC6syngK were not
other mutations that can counteract the effects of the gK statistically significant (P  0.2). Results similar to DgC6 were also
syncytial mutation on sensitivity to heparin inhibition. The obtained with a second gC-negative recombinant, DgC2-3 (data not
shown).revertants DgC6REV and SyngKREV did not differ signifi-
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nant DgC6syngK had a syncytial morphology on both for, since it was detected in all four plaque-purified mu-
tants and probably in 90 to 95% of the virus in the un-cell types. Lack of gC expression alone did not result in
a syncytial phenotype. Therefore, lack of gC expression cloned pools. The recombinant containing the HS3-gK
allele and deleted for gC, DgC6syngK, did not differ fromallowed virus containing the syncytial gK allele to form
syncytia on HEp-2 cells. Interestingly, HS2 and HS4 both DgC6 in resistance to heparin inhibition of viral binding
and penetration. As mentioned above, loss of gC expres-expressed gC and had a syncytial mutation in gK and
yet these two mutants formed syncytial plaques on both sion alone was sufficient to explain the enrichment for
gC-negative mutants in the presence of heparin and,Vero and HEp-2 cells. One possible explanation is that
the additional amino acid substitutions in the gK genes based on the results obtained with DgC6syngK, to abro-
gate the enhanced sensitivity to heparin caused by thefrom these mutants may have overcome any restriction
to syncytium formation on HEp-2 cells that exists for the gK syncytial mutation.
Because the gC-positive heparin-selected mutantsHS3-gK gene. Alternatively, gC or another viral protein
may have been altered in both these mutants, allowing (HS2 and HS4) were somewhat resistant to heparin inhi-
bition and were syncytial on HEp-2 cells, it is unlikelythe formation of syncytia on HEp-2 cells. Regardless of
the explanation for the syncytial phenotype in HS2 and that they carried only the syncytial mutation in gK. One
of several possibilities is that these mutants have alter-HS4, results obtained with SyngK and DgC6syngK show
that both the HS3-gK allele and gC deletion were re- ations in gC structure and function that were not evident
from the immunoassay done.quired for syncytium formation on HEp-2 cells. Viruses
carrying both mutations would, therefore, be more resis- Heparin was added only during the initial binding and
penetration of virus when the pools were selected. Thus,tant than KOS to heparin inhibition of viral entry and
would also be able to spread by cell fusion through HEp- subsequent events in viral replication or spread through
the HEp-2 cell monolayer may have accounted for selec-2 cell monolayers.
tion of the mutated gK gene. Recombinant virus con-
taining only the HS3-gK gene formed syncytia on VeroDISCUSSION
cells but not on HEp-2 cells while virus containing the
HS3-gK gene and deleted for gC expression formed syn-The presence of heparin during initial HSV binding and
penetration provided a selective advantage for replica- cytia on both cell lines. Because the infectivity of gC-
negative virus is 10-fold lower than wild-type virus intion of gC-negative syncytial mutants. Previous reports
have described a syncytial mutant that was obtained the absence of heparin (Herold et al., 1991), syncytium
formation on HEp-2 cells may have facilitated cell-to-cellafter passaging HSV-1(17) in soluble heparin but the syn-
cytial mutation was mapped to the cytoplasmic tail of gB spread of gC-negative mutants in the absence of heparin.
The observation that the recombinant virus containing(Goodman and Engel, 1991; Engel et al., 1993) and not
to gK as reported here. In addition, although the mutant the HS3-gK allele exhibited altered penetration in the
presence of heparin suggests that gK is in the viral enve-was found to be somewhat resistant to heparin inhibition,
the responsible mutation was not mapped. lope or that gK can influence the composition of the
envelope during virion morphogenesis. In a previous re-The selection of gC-negative mutants by the protocol
used can be rationalized based on the results of the port, gK was not detected in purified virions (Hutchinson
et al., 1995). In addition, it has been theorized that aheparin inhibition experiments. The plaque-purified gC-
negative syncytial mutants were relatively resistant to mutated gK may alter the transport of viral proteins that
are directly involved in cell fusion, possibly by changingheparin inhibition of infection. Loss of gC expression
alone appeared to be sufficient to explain this phenotype the composition of the cell membrane (Hutchinson and
Johnson, 1995). If true, an altered form of gK may alsosince these mutants did not differ in resistance from an
engineered nonsyncytial gC-negative recombinant, significantly alter the composition of the envelope of vi-
rion particles released from infected cells.DgC6, and since the gC-positive revertant, DgC6REV,
did not differ from the wild-type strain. Although the phe- An unexpected finding was that heparin could inhibit
penetration as well as binding of HSV-1 and that thenotype was not mapped, the gC-positive mutants exhib-
ited a low level of resistance to heparin inhibition, im- inhibition of penetration on HEp-2 cells was especially
pronounced for virus expressing wild-type gC or wild-plying that gC or another viral glycoprotein such as gB
may have been altered. Similarly, the gC-negative hepa- type gC and the HS3-gK syncytial allele. Possibly gC–
heparin complexes interfere in some way with the pene-rin-selected mutants may also have other mutations but
these changes would not be required to explain the ob- tration process. It was also of interest that a long sus-
pected phenomenon could be confirmed, namely thatserved phenotypes.
Interestingly, the recombinant virus constructed to deletion of gC enabled the syncytial phenotype associ-
ated with gK mutations to be expressed in HEp-2 cells.contain the syncytial form of gK was more sensitive than
wild-type virus to heparin inhibition of penetration. Never- Possibly gC can inhibit cell fusion of some cell types by
competing with gB or some other heparin-binding proteintheless, the gK syncytial mutation was strongly selected
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Minson, T. (1992). Construction and properties of a mutant of herpesfor interaction with glycosaminoglycans that are known
simplex virus type 1 with glycoprotein H coding sequences deleted.to be required for HSV-1-induced cell fusion. The physio-
J. Virol. 66, 341–348.
logical roles of gC are complicated and include activities Fuller, A. O., and Lee, W.-C. (1992). Herpes simplex virus type 1 entry
that can be adequately assessed only in vivo, such as through a cascade of virus–cell interactions requires different roles
of gD and gH in penetration. J. Virol. 66, 5002–5012.complement modulation. The fact that gC expression is
Fuller, A. O., and Spear, P. G. (1987). Anti-glycoprotein D antibodiesmaintained by HSV-1 propagated in cell culture except
that permit adsorption but block infection by herpes simplex virus 1during selection under adverse conditions, such as hepa-
prevent virion–cell fusion at the cell surface. Proc. Natl. Acad. Sci.
rin inhibition as described here or antibody inhibition USA 84, 5454–5458.
(Hoggan and Roizman, 1959; Homa et al., 1986), empha- Gage, P. J., Levine, M., and Glorioso, J. C. (1993). Syncytium-inducing
mutations localize to two discrete regions within the cytoplasmicsizes the role of gC in enhancing infectivity of virions.
domain of herpes simplex virus type 1 glycoprotein B. J. Virol. 67,
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